Cargando…

TAM receptors, Phosphatidylserine, inflammation, and Cancer

ABSTRACT: The numerous and diverse biological roles of Phosphatidylserine (PtdSer) are featured in this special issue. This review will focus on PtdSer as a cofactor required for stimulating TYRO3, AXL and MERTK – comprising the TAM family of receptor tyrosine kinases by their ligands Protein S (PRO...

Descripción completa

Detalles Bibliográficos
Autores principales: Burstyn-Cohen, Tal, Maimon, Avi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881992/
https://www.ncbi.nlm.nih.gov/pubmed/31775787
http://dx.doi.org/10.1186/s12964-019-0461-0
_version_ 1783474057493086208
author Burstyn-Cohen, Tal
Maimon, Avi
author_facet Burstyn-Cohen, Tal
Maimon, Avi
author_sort Burstyn-Cohen, Tal
collection PubMed
description ABSTRACT: The numerous and diverse biological roles of Phosphatidylserine (PtdSer) are featured in this special issue. This review will focus on PtdSer as a cofactor required for stimulating TYRO3, AXL and MERTK – comprising the TAM family of receptor tyrosine kinases by their ligands Protein S (PROS1) and growth-arrest-specific 6 (GAS6) in inflammation and cancer. As PtdSer binding to TAMs is a requirement for their activation, the biological repertoire of PtdSer is now recognized to be broadened to include functions performed by TAMs. These include key homeostatic roles necessary for preserving a healthy steady state in different tissues, controlling inflammation and further additional roles in diseased states and cancer. The impact of PtdSer on inflammation and cancer through TAM signaling is a highly dynamic field of research. This review will focus on PtdSer as a necessary component of the TAM receptor-ligand complex, and for maximal TAM signaling. In particular, interactions between tumor cells and their immediate environment - the tumor microenvironment (TME) are highlighted, as both cancer cells and TME express TAMs and secrete their ligands, providing a nexus for a multifold of cross-signaling pathways which affects both immune cells and inflammation as well as tumor cell biology and growth. Here, we will highlight the current and emerging knowledge on the implications of PtdSer on TAM signaling, inflammation and cancer. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-6881992
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68819922019-12-03 TAM receptors, Phosphatidylserine, inflammation, and Cancer Burstyn-Cohen, Tal Maimon, Avi Cell Commun Signal Review ABSTRACT: The numerous and diverse biological roles of Phosphatidylserine (PtdSer) are featured in this special issue. This review will focus on PtdSer as a cofactor required for stimulating TYRO3, AXL and MERTK – comprising the TAM family of receptor tyrosine kinases by their ligands Protein S (PROS1) and growth-arrest-specific 6 (GAS6) in inflammation and cancer. As PtdSer binding to TAMs is a requirement for their activation, the biological repertoire of PtdSer is now recognized to be broadened to include functions performed by TAMs. These include key homeostatic roles necessary for preserving a healthy steady state in different tissues, controlling inflammation and further additional roles in diseased states and cancer. The impact of PtdSer on inflammation and cancer through TAM signaling is a highly dynamic field of research. This review will focus on PtdSer as a necessary component of the TAM receptor-ligand complex, and for maximal TAM signaling. In particular, interactions between tumor cells and their immediate environment - the tumor microenvironment (TME) are highlighted, as both cancer cells and TME express TAMs and secrete their ligands, providing a nexus for a multifold of cross-signaling pathways which affects both immune cells and inflammation as well as tumor cell biology and growth. Here, we will highlight the current and emerging knowledge on the implications of PtdSer on TAM signaling, inflammation and cancer. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2019-11-27 /pmc/articles/PMC6881992/ /pubmed/31775787 http://dx.doi.org/10.1186/s12964-019-0461-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Burstyn-Cohen, Tal
Maimon, Avi
TAM receptors, Phosphatidylserine, inflammation, and Cancer
title TAM receptors, Phosphatidylserine, inflammation, and Cancer
title_full TAM receptors, Phosphatidylserine, inflammation, and Cancer
title_fullStr TAM receptors, Phosphatidylserine, inflammation, and Cancer
title_full_unstemmed TAM receptors, Phosphatidylserine, inflammation, and Cancer
title_short TAM receptors, Phosphatidylserine, inflammation, and Cancer
title_sort tam receptors, phosphatidylserine, inflammation, and cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881992/
https://www.ncbi.nlm.nih.gov/pubmed/31775787
http://dx.doi.org/10.1186/s12964-019-0461-0
work_keys_str_mv AT burstyncohental tamreceptorsphosphatidylserineinflammationandcancer
AT maimonavi tamreceptorsphosphatidylserineinflammationandcancer